Steve N. Sealey
Vorsitzender bei Hope Capital Ltd.
Ursprung des Netzwerks ersten Grades von Steve N. Sealey
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
Aquarius Equity Partners Ltd.
 Aquarius Equity Partners Ltd. Investment ManagersFinance Aquarius Equity Partners Ltd is an independent private equity firm founded in the year 2002 by Alan John Aubrey and Duncan Joseph Peyton headquarters in the UK.
3
| Private Company | Investment Managers | 3 |
Hope Capital Ltd.
 Hope Capital Ltd. Finance/Rental/LeasingFinance Hope Capital Ltd. provides credits granting services. The firm specializes in bridging finance, property and investment. The company was founded by Jonathan Robert Sealey on September 23, 2011 and is headquartered in Merseyside, the United Kingdom.
3
| Private Company | Finance/Rental/Leasing | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Steve N. Sealey
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
Modern Biosciences Ltd.
 Modern Biosciences Ltd. Pharmaceuticals: MajorHealth Technology Part of Istesso Ltd., Modern Biosciences Ltd. is a British pharmaceutical company that manufactures pharmaceutical products. The company is based in London, UK. The company was founded by Samuel Cameron Williams, Alexander James Stevenson. Samuel Cameron Williams has been the CEO since incorporation. | Pharmaceuticals: Major | Founder | |
| University of Leeds | College/University | Doctorate Degree | |
| AVACTA GROUP PLC | Miscellaneous Commercial Services | President | |
GT Biologics Ltd.
 GT Biologics Ltd. Pharmaceuticals: MajorHealth Technology GT Biologics Ltd. manufactures and distributes pharmaceutical products. It develops and commercializes an oral-based probiotic product for the treatment of mild to moderate Crohn's disease and ulcerative colitis and a novel family of protein, peptide therapeutics for the treatment of moderate to severe inflammatory bowel diseases. The company was founded by Denise Kelly in 2008 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
C4X Discovery Ltd.
 C4X Discovery Ltd. Pharmaceuticals: MajorHealth Technology C4X Discovery Ltd. engages in the discovery and development of medical drugs. It uses its NMR-based technology to solve the dynamic 3D structures of a broad range of biomolecules, including peptides, cofactors, oligonucleotides and carbohydrates. The company was founded by Andrew Almond and Charles Douglas Blundell in January 2008 and is headquartered in Manchester, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| North West Seed Fund General Partner Ltd. | Director/Board Member | ||
| Aquarius Origin Fund Managing Member Ltd. | Director/Board Member | ||
| TISSUE REGENIX GROUP PLC | Medical Specialties | Director/Board Member | |
Aquarius Equity Holdings Ltd.
 Aquarius Equity Holdings Ltd. Financial ConglomeratesFinance Aquarius Equity Holdings Ltd. functions as an investment holding British company. The private company is based in Manchester, UK. and has subsidiaries in United Kingdom. | Financial Conglomerates | Director/Board Member | |
| Aquarius Northern Entrepreneurs Managing Member Ltd. | Director/Board Member | ||
Zogenix International Ltd.
 Zogenix International Ltd. Pharmaceuticals: MajorHealth Technology Zogenix International Ltd. manufactures and markets pharmaceutical products. It develops Brabafen an oral treatment for use in children with Dravet Syndrome or severe myoclonic epilepsy of infancy. The company was founded in 2012 and is headquartered in Maidenhead, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
| 4D PHARMA PLC | Pharmaceuticals: Major | Founder | |
| Aquarius Equity Director Ltd. | Director/Board Member | ||
| Aquarius IV Fund Managing Member Ltd. | Director/Board Member | ||
| Aquarius Life Science Ltd. | Director/Board Member | ||
| Schosween 18 Ltd. | Director/Board Member | ||
The Microbiota Co. Ltd.
 The Microbiota Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of 4D Pharma Plc, The Microbiota Co. Ltd. develops a patented bacteria which treats irritable bowel syndrome and related symptoms. The company is based in Manchester, UK. The Microbiota Co. was acquired by 4D Pharma Plc on July 18, 2014 for $1.65 million. | Pharmaceuticals: Major | Director/Board Member | |
| C4X DISCOVERY HOLDINGS PLC | Pharmaceuticals: Major | Director/Board Member | |
Hope Capital 2 Ltd.
 Hope Capital 2 Ltd. Financial ConglomeratesFinance Part of Hope Capital Ltd., Hope Capital 2 Ltd. provides investment services. The company is based in Bootle, UK. Founded in 2017. | Financial Conglomerates | Director/Board Member |
Statistik
International
| Vereinigtes Königreich | 20 |
Sektoral
| Health Technology | 9 |
| Finance | 3 |
| Consumer Services | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 18 |
| Private Equity Investor | 3 |
| Founder | 3 |
| Chief Operating Officer | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Steve N. Sealey
- Unternehmensverbindungen
